Lb Pharmaceuticals Inc · NASDAQ:LBRX
JPMorgan Chase & Co's stake in Lb Pharmaceuticals Inc fell to 4.90% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 13, 2026
JPMorgan Chase & Co's stake in Lb Pharmaceuticals Inc fell to 4.90%, 1,427,568 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 1,427,568
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO | 4.90% | 1,427,568 |
Source
Related
- Lb Pharmaceuticals Inc
- JPMorgan Chase & Co
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G · JPMorgan Chase & Co · Jan 21, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G · Caligan Partners LP · May 15, 2026
- Schedule 13G/A · Commodore Capital LP · May 15, 2026